Wednesday, February 10, 2010, 2:59pm SGT - The Singapore stock market closes in 2 hours and 1 minute.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEINVESTINGFINANCE NEWS
    Market:       |  

Jazz Pharmaceuticals, Inc. (JAZZ)

At 5:00AM SGT: 9.18 USD  Up 0.05 (0.55%)  
 MORE ON JAZZ 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 Jazz Pharmaceuticals, Inc. (NGM:JAZZ) Delayed quote dataEdit
After Hours: 9.05 Down 0.13 (1.42%) as of 5:25am SGT on 02/10/10
Last Trade:9.18 USD
Trade Time:5:00AM SGT
Change:Up 0.05 (0.55%)
Prev Close:9.13
Open:9.26
Bid:8.38 x 100
Ask:9.65 x 600
1y Target Est:10.00
Day's Range:9.15 - 9.45
52wk Range:0.52 - 11.88
Volume:72,043
Avg Vol (3m):349,919
Market Cap:284.51M
P/E (ttm):N/A
EPS (ttm):-2.38
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y 
Use Y! Toolbar to track stocks
 Add JAZZ to Portfolio   Download Data

 HEADLINES 
•Emerging Stock Report Initiates Independent Research Coverage on Jazz Pharmaceuticals, Inc.
GlobeNewswire (Sat, Jan 23)
•JAZZ PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
EDGAR Online (Thu, Jan 21)
•Jazz Pharmaceuticals to Present at 2010 J.P. Morgan Healthcare Conference
PR Newswire (Fri, Jan 8)
•Lightning Round OT: Tekelec, Jazz Pharma and More
at CNBC (Thu, Dec 17)
•Jazz Pharmaceuticals Submits New Drug Application for JZP-6 (sodium oxybate) for the Treatment of Fibromyalgia
PR Newswire (Tue, Dec 15)
•[$$] Dollar Drives the Action
at RealMoney by TheStreet.com (Thu, Dec 10)
•Stock Watch: InvestorSoup.com Issues Market Alert for Jazz Pharmaceuticals Inc.
GlobeNewswire (Thu, Dec 10)
•Buying Strength? Don't Do It! 3 PowerRatings Stocks To Test
TradingMarkets.com (Wed, Dec 9)
•Coverage initiated on Jazz Pharma by Jefferies & Co
Briefing.com (Wed, Dec 9)
•Jazz Pharmaceuticals appoints ARCA exec as CFO
AP (Fri, Dec 4)
More Headlines for JAZZ...
 ANALYST 
EPS Est (next year) (Dec-09) :-0.36
EPS Est (in 2 years) (Dec-10) :0.39
Avg Rec (current)*:2.5
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Jazz Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and commercializes products for neurology and psychiatry primarily in the United States.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
•Latest News•Singapore Indices